首页
探索
nav.journalClub
趋势
更多
synapse
⌘+K
语言
简体中文
简体中文
Metabolome profiling by HRMAS NMR spectroscopy in pancreatic adenocarcinoma | Synapse
March 3, 2026
Metabolome profiling by HRMAS NMR spectroscopy in pancreatic adenocarcinoma
SB
S. Battini
Laboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie
AI
A. Imperiale
Laboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie
KE
K. Elbayed
Laboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie
See all
Key Points
Metabolome profiling reveals distinct biomarkers associated with pancreatic adenocarcinoma.
In-depth NMR spectroscopy analysis highlights specific metabolic alterations in cancerous tissue.
The study assesses metabolic changes in tumor samples, aiming to improve diagnostic approaches.
Findings may enable the development of targeted interventions in pancreatic cancer management.
Abstract
International audience
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Battini et al. (Thu,) studied this question.
synapsesocial.com/papers/69a760edc6e9836116a2e364
Mark Helpful
Like
Save
Bookmark
Relay
Share